Tim Kaine actually said...

"In your thinking about this free market system you are describing, is it a factor of relevance at all that the absence of a drug, a dermatological drug, might cause, you know, a minor concern and the ..."

"I think we have been too aggressive--too aggressive on pricing."

"the challenges associated with developing treatments and the investments we make to develop novel medicines, that is really completely a red herring with respect to Syprine."

"When did that realization strike you that you were basically making a drug that some people needed to stay alive?"